[HTML][HTML] Gut microbiota and clinical disease: obesity and nonalcoholic fatty liver disease
JS Park, JH Seo, HS Youn - Pediatric gastroenterology, hepatology …, 2013 - ncbi.nlm.nih.gov
JS Park, JH Seo, HS Youn
Pediatric gastroenterology, hepatology & nutrition, 2013•ncbi.nlm.nih.govThe prevalence of obesity is increasing worldwide. Obesity can cause hyperlipidemia,
hypertension, cardiovascular diseases, metabolic syndrome and non-alcoholic fatty liver
disease (NAFLD). Many environmental or genetic factors have been suggested to contribute
to the development of obesity, but there is no satisfactory explanation for its increased
prevalence. This review discusses the latest updates on the role of the gut microbiota in
obesity and NAFLD.
hypertension, cardiovascular diseases, metabolic syndrome and non-alcoholic fatty liver
disease (NAFLD). Many environmental or genetic factors have been suggested to contribute
to the development of obesity, but there is no satisfactory explanation for its increased
prevalence. This review discusses the latest updates on the role of the gut microbiota in
obesity and NAFLD.
Abstract
The prevalence of obesity is increasing worldwide. Obesity can cause hyperlipidemia, hypertension, cardiovascular diseases, metabolic syndrome and non-alcoholic fatty liver disease (NAFLD). Many environmental or genetic factors have been suggested to contribute to the development of obesity, but there is no satisfactory explanation for its increased prevalence. This review discusses the latest updates on the role of the gut microbiota in obesity and NAFLD.
ncbi.nlm.nih.gov